Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases

Area of Science:

• Immunology and Infectious Diseases
• Therapeutic Interventions
• Public Health Preparedness

Background:

• Convalescent plasma (CP) emerged as a potential treatment during past pandemics.
• Current evidence supports the safety and potential efficacy of CP for COVID-19.
• The FDA has authorized CP for COVID-19 under emergency use, pending further studies.

Purpose of the Study:

• To review the current status of CP therapy for COVID-19.
• To identify challenges in implementing CP therapy.
• To propose a framework for pandemic preparedness regarding CP deployment.

Main Methods:

• Literature review of existing studies on CP for COVID-19.
• Analysis of challenges in CP therapy implementation.
• Development of a preparedness framework for future outbreaks.

Main Results:

• CP therapy is safe and shows preliminary efficacy for COVID-19.
• Implementation of CP therapy faces several challenges.
• A structured, interdisciplinary approach is crucial for preparedness.

Conclusions:

• CP is a viable therapeutic option for COVID-19, necessitating further research.
• Overcoming implementation challenges is key to successful CP deployment.
• A robust pandemic preparedness framework is essential for future health crises.